To include your compound in the COVID-19 Resource Center, submit it here.

Dermagraft: Development discontinued

Shire said it will discontinue development of Dermagraft to treat venous leg ulcers after top-line data from the

Read the full 187 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE